Buy MK-2866 (Ostarine) Capsules – Next LVL Muscle

Product Overview

MK-2866 Ostarine Capsules provide premium, brandless research chemical encapsulated at ≥98% purity for sophisticated laboratory applications in analytical chemistry and selective receptor modulator investigations. This reference standard enables qualified researchers to analyze molecular stereochemistry, solubility dynamics, and binding characteristics under strictly controlled in vitro conditions. The capsule format ensures dust-free dosing accuracy and batch consistency, ideal for reproducible non-clinical protocols in institutional settings.

For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications.​

Chemical Identity & Classification

MK-2866 Ostarine holds CAS number 841205-47-8, securing precise identification across global chemical databases. Its molecular formula C19H14F3N3O3 yields a molecular weight of 389.33 g/mol, supplying critical metrics for quantitative assays and instrumental calibration. Synonyms such as Enobosarm, GTX-024, and (2S)-3-(4-cyanophenoxy)-N-[4-cyano-3-(trifluoromethyl)phenyl]-2-hydroxy-2-methylpropanamide classify it as a nonsteroidal synthetic analytical reagent and reference standard for selective androgen receptor modulator studies. This designation aligns it with in vitro analytical tools managed by trained laboratory professionals.

Chemical & Physical Characteristics

The active MK-2866 Ostarine within capsules appears as a white to off-white solid, contained in standard research-grade shells for contamination-free handling. Solubility reaches approximately 25 mg/mL in ethanol, 15 mg/mL in DMSO and DMF, with sparing solubility in aqueous buffers, guiding solvent selection for dissolution and extraction protocols. Key properties include the (S)-configuration at C2, LogP ~2.7 indicating moderate lipophilicity, density around 1.5 g/cm³, and stability requiring -20°C storage, with cyano and trifluoromethyl groups contributing electronic characteristics for spectroscopic analysis. These attributes support consistent HPLC performance, LC-MS confirmation (m/z 390 [M+H]+), and NMR structural validation.

Purity & Analytical Verification

MK-2866 Ostarine Capsules achieve ≥98% purity per batch, verified via High-Performance Liquid Chromatography (HPLC), Liquid Chromatography-Mass Spectrometry (LC-MS), Nuclear Magnetic Resonance (NMR), and optical rotation analysis confirming (S)-stereochemistry. Controls limit heavy metals to <5 ppm, residual solvents to ICH standards, and chiral impurities, meeting reference material specifications. Certificates of Analysis (COAs) document purity levels, spectral data, enantiomeric excess (>99%), and water content for laboratory records. This orthogonal verification ensures reliability for calibration standards and purity profiling.

Quality Control & Batch Integrity

Capsule production employs unique lot coding for full traceability from synthesis through sterile filling and release testing. Multi-stage QC assesses fill uniformity, potency retention, and stereochemical integrity, with third-party validation for stability and contaminants. ICH-compliant studies confirm 24-36 month shelf life under refrigeration, retaining samples for re-analysis. Manufacturing documentation includes yield optimization, purification chromatograms, and process controls, supporting serial experiments and quality audits. Statistical process monitoring achieves lot-to-lot equivalence for dependable research outcomes.

Safety, Handling & Laboratory Precautions

Trained personnel must manipulate MK-2866 Ostarine Capsules in ventilated analytical labs using PPE: nitrile gloves, goggles, lab coats, and fume hoods. Verify capsule integrity; compromised units require inert absorbent containment and SDS-directed decontamination. Documentation classifies irritancy potential (GHS07), requiring eyewash stations and exposure minimization protocols. Hazardous waste follows institutional incineration procedures under authorized supervision.

Packaging, Labeling & Storage

Supplied in tamper-evident HDPE bottles or blisters with desiccants, MK-2866 Ostarine Capsules feature labels denoting CAS 841205-47-8, formula, ≥98% purity, lot details, and GHS symbols. Store at -20°C desiccated and protected from light; aliquoting prevents moisture ingress, maintaining integrity for 36 months.

Intended Research Use & Market Positioning

MK-2866 Ostarine Capsules target analytical chemistry, SARM validation, forensic standards, and receptor binding studies in encapsulated format. They enable Ki determinations (3.8 nM AR), selectivity assessments, and agonist profiling in vitro reporter systems. As “Next LVL Muscle” grade generic ≥98% purity material, it supports economical high-throughput screening. Critical for SAR mapping, tissue selectivity research, and analytical method development in controlled settings.

Ordering, Availability & Fulfillment

MK-2866 Ostarine Capsules stock securely for immediate WooCommerce purchase with encrypted payments. Discreet tracked shipping delivers globally in 3-7 days; support handles COAs and queries efficiently.

Legal & Regulatory Disclaimer

MK-2866 Ostarine Capsules (CAS 841205-47-8) sold for laboratory research purposes only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications. Buyers ensure regulatory compliance independently.